Homology modeling and structural analysis of 11β-hydroxysteroid dehydrogenase type 2

European Journal of Medicinal Chemistry

Volumn 46, Issue 4, 2011, Pages 1325-1330

  Yamaguchi, Hideaki ^a   Akitaya, Tatsuo ^a   Yu, Tao ^b   Kidachi, Yumi ^c   Kamiie, Katsuyoshi ^c   Noshita, Toshiro ^d   Umetsu, Hironori ^e   Ryoyama, Kazuo ^c  

^a MEIJO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AOMORI UNIVERSITY   (Japan)

^d PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^e GIFU SHOTOKU GAKUEN UNIVERSITY   (Japan)

Author keywords

11 HSD2; Anticancer drug; Homology modeling; Molecular Operating Environment (MOE); Tumor

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; HYDROCORTISONE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

AMINO ACID COMPOSITION; ARTICLE; BETA SHEET; BINDING SITE; COMPUTER PROGRAM; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME STRUCTURE; LIGAND BINDING; MOLECULAR MODEL; NUCLEOTIDE SEQUENCE; PROTEIN SECONDARY STRUCTURE; RESIDUE ANALYSIS; STATIC ELECTRICITY; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; AMINO ACID SEQUENCE; BINDING SITES; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; SEQUENCE HOMOLOGY, AMINO ACID; SOFTWARE; STATIC ELECTRICITY; STEREOISOMERISM; THERMODYNAMICS;

EID: 79952280980     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2011.01.054     Document Type: Article

References (42)

1. Y. Kallberg, U. Oppermann, H. Jornvall, and B. Persson Short-chain dehydrogenase/reductase (SDR) relationships: a large family with eight clusters common to human, animal, and plant genomes Protein Sci. 11 2002 636 641 (Pubitemid 34173025)
2. H. Jornvall, B. Persson, M. Krook, S. Atrian, R. Gonzalez-Duarte, J. Jeffery, and D. Ghosh Short-chain dehydrogenases/reductases (SDR) Biochemistry 34 1995 6003 6013
3. J. Obeid, and P.C. White Tyr-179 and Lys-183 are essential for enzymatic activity of 11 beta-hydroxysteroid dehydrogenase Biochem. Biophys. Res. Commun. 188 1992 222 227
4. U.C. Oppermann, C. Filling, K.D. Berndt, B. Persson, J. Benach, R. Ladenstein, and H. Jornvall Active site directed mutagenesis of 3 beta/17 beta-hydroxysteroid dehydrogenase establishes differential effects on short-chain dehydrogenase/reductase reactions Biochemistry 36 1997 34 40 (Pubitemid 27024675)
5. C. Filling, K.D. Berndt, J. Benach, S. Knapp, T. Prozorovski, E. Nordling, R. Ladenstein, H. Jornvall, and U.C. Oppermann Critical residues for structure and catalysis in shortchain dehydrogenases/reductases J. Biol. Chem. 277 2002 25677 25684 (Pubitemid 34959957)
6. F. Hoffmann, and E. Maser Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily Drug Metab. Rev. 39 2007 87 144
7. P.M. Stewart, A. Boulton, S. Kumar, P.M. Clark, and C.H. Shackleton Cortisol metabolism in human obesity: impaired cortisone-cortisol conversion in subjects with central adiposity J. Clin. Endocrinol. Metab. 84 1999 1022 1027 (Pubitemid 29138237)
8. M.L. Ricketts, J.M. Verhaeg, I. Bujalska, A.J. Howie, W.E. Rainey, and P.M. Stewart Immunohistochemical localization of type 1 11β-hydroxysteroid dehydrogenase in human tissues J. Clin. Endocrinol. Metab. 83 1998 1325 1335 (Pubitemid 28496416)
9. P.S. Brereton, R.R. van Driel, F. Suhaimi, K. Koyama, R. Dilley, and Z. Krozowski Light and electron microscopy localization of the 11β- hydroxysteroid dehydrogenase type I enzyme in the rat Endocrinology 142 2001 1644 1651 (Pubitemid 32299695)
10. J.W. Tomlinson, I. Bujalska, P.M. Stewart, and M.S. Cooper The role of 11β-hydroxysteroid dehydrogenase in central obesity and osteoporosis Endocr. Res. 26 2000 711 722 (Pubitemid 32053094)
11. G. Wolf Glucocorticoids in adipocytes stimulate visceral obesity Nutr. Rev. 60 2002 148 151 (Pubitemid 34525610)
12. R. Diaz, R.W. Brown, and J.R. Seckl Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions J. Neurosci. 18 1998 2570 2580
13. A. Audige, B. Dick, B.M. Frey, F.J. Frey, B. Corman, and B. Vogt Glucocorticoids and 11β-hydroxysteroid dehydrogenase type 2 gene expression in the aging kidney Eur. J. Clin. Invest. 32 2002 411 420 (Pubitemid 36223431)
14. S. Kataoka, A. Kudo, H. Hirano, H. Kawakami, T. Kawano, E. Higashihara, H. Tanaka, F. Delarue, J.D. Sraer, T. Mune, Z.S. Krozowski, and K. Yan 11β-hydroxysteroid dehydrogenase type 2 is expressed in the human kidney glomerulus J. Clin. Endocrinol. Metab. 87 2002 877 882 (Pubitemid 34158267)
15. Z.S. Krozowski, P.M. Stewart, V.R. Obeyesekere, K. Li, and P. Ferrari Mutations in the 11β-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth Clin. Exp. Hypertens. 19 1997 519 529 (Pubitemid 27321684)
16. Y. Kotelevtsev, R.W. Brown, S. Fleming, C. Kenyon, C.R. Edwards, J.R. Seckl, and J.J. Mullins Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2 J. Clin. Invest. 103 1999 683 689 (Pubitemid 29122421)
17. K. Lin-Su, P. Zhou, N. Arora, B.P. Betensky, M.I. New, and R.C. Wilson In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess J. Clin. Endocrinol. Metab. 89 2004 2024 2027 (Pubitemid 38619827)
18. E.R. De Kloet, S.A. Van Acker, R.M. Sibug, M.S. Oitzl, O.C. Meijer, K. Rahmouni, and W. de Jong Brain mineralocorticoid receptors and centrally regulated functions Kidney Int. 57 2000 1329 1336 (Pubitemid 30207887)
19. E.H. Rabbitt, G.G. Lavery, E.A. Walker, M.S. Cooper, P.M. Stewart, and M. Hewison Prereceptor regulation of glucocorticoid action by 11β- hydroxysteroid dehydrogenase: a novel determinant of cell proliferation FASEB J. 16 2002 36 44 (Pubitemid 34027948)
20. M. Zhang, J. Xu, B. Yao, H. Yin, Q. Cai, M.J. Shrubsole, X. Chen, V. Kon, W. Zheng, A. Pozzi, and R.C. Harris Inhibition of 11β-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans J. Clin. Invest. 119 2009 876 885
21. T. Nigawara, Y. Iwasaki, M. Asai, M. Yoshida, M. Kambayashi, H. Sashinami, K. Hashimoto, and T. Suda Inhibition of 11β-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells Endocrinology 147 2006 769 772 (Pubitemid 43112993)
22. K. Koyama, K. Myles, R. Smith, and Z. Krozowski Expression of the 11β-hydroxysteroid dehydrogenase type II enzyme in breast tumors and modulation of activity and cell growth in PMC42 cells J. Steroid Biochem. Mol. Biol. 76 2001 153 159 (Pubitemid 32510677)
23. P.G. Cohen Estradiol induced inhibition of 11β-hydroxysteroid dehydrogenase 1: an explanation for the postmenopausal hormone replacement therapy effects Med. Hypotheses 64 2005 989 991 (Pubitemid 40385956)
24. S. Zbankova, J. Bryndova, M. Kment, and J. Pacha Expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer Cancer Lett. 210 2004 95 100 (Pubitemid 38692593)
25. H. Yamaguchi, T. Noshita, T. Yu, Y. Kidachi, K. Kamiie, H. Umetsu, and K. Ryoyama Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity Eur. J. Med. Chem. 45 2010 2943 2948
26. Y. Kurogi, and O.F. Guner Pharmacophore modeling and threedimensional database searching for drug design using catalyst Curr. Med. Chem. 8 2001 1035 1055 (Pubitemid 32633658)
27. S. Ekins Predicting undesirable drug interactions with promiscuous proteins in silico Drug Discov. Today 9 2004 276 285 (Pubitemid 38328514)
28. W.L. Jorgensen The many roles of computation in drug discovery Science 303 2004 1813 1818 (Pubitemid 38374866)
29. L. Miguet, Z. Zhang, M. Barbier, and M.G. Grigorov Comparison of a homology model and the crystallographic structure of human 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in a structure-based identification of inhibitors J. Comput. Aided Mol. Des 20 2006 67 81 (Pubitemid 43899118)
30. M. Levitt Accurate modeling of protein conformation by automatic segment matching J. Mol. Biol. 226 1992 507 533
31. T. Fechteler, U. Dengler, and D. Schomberg Prediction of protein three-dimensional structures in insertion and deletion regions: a procedure for searching data bases of representative protein fragments using geometric scoring criteria J. Mol. Biol. 253 1995 114 131
32. C. Zhang, G. Vasmatizis, J.L. Cornette, and C. DeLisi Determination of atomic desolvation energies from the structures of crystallized proteins J. Mol. Biol. 267 1997 707 726 (Pubitemid 27170692)
33. S.C. Lovell, I.W. Davis, W.B. Arendall III, P.I. de Bakker, J.M. Word, M.G. Prisant, J.S. Richardson, and D.C. Richardson Structure validation by Cα geometry: φ, ψ and Cβ deviation Proteins 50 2003 437 450
34. C.A. Carvajal, A.A. Gonzalez, D.G. Romero, A. González, L.M. Mosso, E.T. Lagos, M. Hevia, P. del, M.P. Rosati, T.O. Perez-Acle, C.E. Gomez-Sanchez, J.A. Montero, and C.E. Fardella Two homozygous mutations in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess J. Clin. Endocrinol. Metab. 88 2003 2501 2507 (Pubitemid 36724415)
35. M. Awale, V. Kumar, P. Saravanan, and C.G. Mohan Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors J. Mol. Model. 16 2010 475 488
36. X.T. Ni, T. Duan, Z. Yang, C.M. Guo, J.N. Li, and K. Sun Role of human chorionic gonadotropin in maintaining 11beta-hydroxysteroid dehydrogenase type 2 expression in human placental syncytiotrophoblasts Placenta 30 2009 1023 1028
37. Z.K. Wan, E. Chenail, J. Xiang, H.Q. Li, M. Ipek, J. Bard, K. Svenson, T.S. Mansour, X. Xu, X. Tian, V. Suri, S. Hahm, Y. Xing, C.E. Johnson, X. Li, A. Qadri, D. Panza, M. Perreault, J.F. Tobin, and E. Saiah Efficacious 11β-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model J. Med. Chem. 52 2009 5449 5461
38. J.U. Bowie, R. Lüthy, and D. Eisenberg A method to identify protein sequences that fold into a known three-dimensional structure Science 253 1991 164 170 (Pubitemid 21917131)
39. R. Lüthy, J.U. Bowie, and D. Eisenberg Assessment of protein models with three-dimensional profiles Nature 356 1992 83 85
40. J. Liang, H. Edelsbrunner, P. Fu, P.V. Sudhakar, and S. Subramaniam Analytical shape computation of macromolecules: I. Molecular area and volume through alpha shape Proteins 33 1998 1 17 (Pubitemid 28413009)
41. J. Liang, H. Edelsbrunner, P. Fu, P. Sudhakar, and S. Subramaniam Analytical shape computation of macromolecules: II. Inaccessible cavities in proteins Proteins 33 1998 18 29 (Pubitemid 28413010)
42. J. Goto, R. Kataoka, and N. Hirayama Ph4Dock: pharmacophore-based protein-ligand docking J. Med. Chem. 47 2004 6804 6811